Therapeutic Drug Monitoring Market

The global therapeutic drug monitoring market is foreseen to grow by 8.8%, from USD 15.75 Billion in 2021 to USD 3.42 Billion in 2029. Growing focus on R&D related to tdm, importance of tdm in organ transplant procedures, increasing preference for precision medicine is to drive the market for the upcoming forecast period. However, reluctance of small hospitals to offer tdm services, requirement of high capital investments remains one factor hindering the market growth over the anticipated period.

Market Definition

What is Therapeutic drug monitoring?

Therapeutic drug monitoring (TDM) is testing that measures the amount of certain medicines in your blood. It is done to make sure the amount of medicine you are taking is both safe and effective.

Market Overview

The therapeutic drug monitoring market search study helps to thoroughly understand the current trend in the market competitive analysis of the players in the emerging market. Moreover, the DRO in the therapeutic drug monitoring market offers valuable perspicuity and a current scenario for making the right decision. The research study covers the eminent players in the market with a detailed analysis of the company and a financial overview containing their net sales, business mix and geographical reach It mainly focuses on the key developments of the products/services offered by the company in recent years. Besides, we at Zettabyte have the expertise to analyses the global therapeutic drug monitoring market player's competitive landscape helping the client comprehend their specific strategic growth approaches.

Therapeutic drug monitoring market study by "Zettabyte Analytics" offers details about the market scope, market segmentation, technological advancement in the therapeutic drug monitoring market and highlights the optimistic, competitive landscape and trends enduring over the years.

Major players in the therapeutic drug monitoring market include Aalto Scientific, Ltd., Abbott, Apdia Group, Ark Diagnostics, Inc., Biomérieux Sa, Bio-Rad Laboratories, Biotez Berlin Buch Gmbh, Bühlmann Laboratories, Cambridge Life Sciences Limited, Danaher Corporation, Diasystem Scandinavia Ab, Eagle Biosciences, Inc., Exagen Inc., F. Hoffmann-La Roche, Grifols S.A., Hromsystems Instruments & Chemicals Gmbh, Immundiagnostik Ag., Jasem Laboratory Systems And Solutions, Randox Laboratories Ltd., R-Biopharm Ag, Sekisui Medical Co., Ltd., Siemens Healthineers Ag, Theradiag Sa., Thermo Fisher Scientific, Utak.

COVID-19 Impact on Global Therapeutic drug monitoring Market

The global impact of COVID-19 has lost millions of lives with a massive cost to the healthcare system. Moreover, the treatment cost for patients with COVID-19 has also had a financial impact globally. the impact of COVID-19 on the therapeutic drug monitoring market has forced the companies to change their sourcing, pricing, and promotion strategies. the therapeutic drug monitoring market players are seen focusing more on optimizing the e-commerce networks with the rising innovations in the digital sector, which are creating new business models for the healthcare industry player.

Research Scope

The report provides market value for the base year 2021 and a yearly forecast from 2022 to 2029 in revenue (USD Million/ Billion). the market for each segment is present in North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the regional basis for the forecast mentioned above.

Key industry dynamics, regulatory scenarios, major material dynamics and therapeutic drug monitoring market future markets are analyzed to understand their impact on demand for the forecast period. growth rates have been estimated using correlation, regression and time-series analysis.

Market Segmentation

For the purpose of this report, the global therapeutic drug monitoring market segmented on the basis of product type, technology, class of drug, end user, and region:

Product Type Outlook:

On the basis of Product Type, the market is segmented into Equipment, Consumables. Further, Equipment is segmented into Immunoassay Analyzers, Chromatography and MS Detectors, Clinical Chemistry Analyzers.

Technology Outlook:

On the basis of Technology, the market is segmented into Immunoassays, Chromatography-Mass spectrometry. Further, Immunoassays is segmented into Radioimmunoassays, Colorimetric Immunoassays, Other Immunoassays. Further, Chromatography-Mass spectrometry is segmented into Liquid chromatography/mass spectrometry (LC-MS), Gas Chromatography-Mass Spectrometry.

Figure 1 Therapeutic drug monitoring Market By Technology (Market Size And Forecast By Value - USD Million, 2021 & 2029)

Class of Drug Outlook:

On the basis of Class of Drug, the market is segmented into Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other drug classes.

End Use Outlook:

On the basis of End User, the market is segmented into Commercial/Private Labs, Hospital Labs, Other End Users.

Figure 2 End Use Outlook (Revenue, USD Million, 2021)

Regional Outlook (Revenue, USD million; 2021 & 2029)

Figure 3 Therapeutic Drug Monitoring Market: Regional Dynamics